Search Results - "Pocock, Stuart J."

Extension Reports in Clinical Trials: A Systematic Review and Consequent Guidance.

Authors: Rossello, Xavier Pocock, Stuart J. Taylor, Dylan et al.

Source: Journal of the American College of Cardiology (JACC). Apr2026, Vol. 87 Issue 15, p1873-1888. 16p.

β blockers after myocardial infarction with mildly reduced ejection fraction: an individual patient data meta-analysis of randomised controlled trials.

Authors: Rossello, Xavier Prescott, Eva Irene Bossano Kristensen, Anna Meta Dyrvig et al.

Source: Lancet. Sep2025, Vol. 406 Issue 10508, p1128-1137. 10p.

Subjects: Myocardial infarction, Adrenergic beta blockers, Ventricular ejection fraction, Heart failure, Medical record databases, Randomized controlled trials, Treatment effectiveness

The win ratio method in heart failure trials: lessons learnt from EMPULSE.

Authors: Pocock, Stuart J. Ferreira, João Pedro Collier, Timothy J. et al.

Source: European Journal of Heart Failure. May2023, Vol. 25 Issue 5, p632-641. 10p. 2 Diagrams, 3 Charts, 1 Graph.

Biomarker‐driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR–Preserved trial.

Authors: Pocock, Stuart J. Ferreira, João Pedro Packer, Milton et al.

Source: European Journal of Heart Failure. Oct2022, Vol. 24 Issue 10, p1869-1878. 10p. 2 Charts, 5 Graphs.

Competing Risks in Clinical Trials: Do They Matter and How Should We Account for Them?

Authors: Gregson, John Pocock, Stuart J. Anker, Stefan D. et al.

Source: Journal of the American College of Cardiology (JACC). Sep2024, Vol. 84 Issue 11, p1025-1037. 13p.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Primary and Secondary Outcome Reporting in Randomized Trials: JACC State-of-the-Art Review.

Authors: Pocock, Stuart J. Rossello, Xavier Owen, Ruth et al.

Source: Journal of the American College of Cardiology (JACC). Aug2021, Vol. 78 Issue 8, p827-839. 13p.

Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved.

Authors: Rogers, Jennifer K. Pocock, Stuart J. McMurray, John J.V. et al.

Source: European Journal of Heart Failure. Jan2014, Vol. 16 Issue 1, p33-40. 8p.

How to interpret figures in reports of clinical trials.

Authors: Pocock, Stuart J. Travison, Thomas G. Wruck, Lisa M.

Source: Clinical Otolaryngology. Aug2008, Vol. 33 Issue 4, p354-358. 5p. 4 Diagrams, 4 Graphs.

Figures in clinical trial reports: current practice & scope for improvement.

Authors: Pocock, Stuart J. Travison, Thomas G. Wruck, Lisa M.

Source: Trials. 2007, Vol. 8, p36-52. 17p.

The pros and cons of noninferiority trials.

Authors: Pocock, Stuart J.¹

Source: Fundamental & Clinical Pharmacology. Aug2003, Vol. 17 Issue 4, p483-490. 8p.

Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls.

Authors: Pocock, Stuart J Clayton, Tim C Altman, Douglas G

Source: Lancet. 5/11/2002, Vol. 359 Issue 9318, p1686. 4p. 3 Graphs.

Subjects: Clinical trials, Medical research, Charts, diagrams, etc., Research

SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials.

Authors: Zannad, Faiez Ferreira, João Pedro Pocock, Stuart J et al.

Source: Lancet. 9/19/2020, Vol. 396 Issue 10254, p819-829. 11p.

Subjects: Dapagliflozin, Empagliflozin, Boehringer Ingelheim Pharmaceuticals Inc., Heart failure patients, Proportional hazards models, Treatment effectiveness, Type 2 diabetes, Angiotensin receptors, Benzene, Glomerular filtration rate, Causes of death, Clinical trials, Combination drug therapy, Meta-analysis, Systematic reviews, Glycosides, Health outcome assessment, Proteolytic enzymes, Case-control method, Hospital care, Stroke volume (Cardiac output), Body mass index, Death, Heart failure, Chemical inhibitors, Disease complications

Geographic Terms: New York (State)

Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries.

Authors: Brieger, David Pocock, Stuart J. Blankenberg, Stefan et al.

Source: International Journal of Cardiology. Jul2020, Vol. 311, p7-14. 8p.

Meta-analysis of randomised trials comparing coronary...

Authors: Pocock, Stuart J Henderson, Robert A Rickards, Anthony F et al.

Source: Lancet. 11/4/1995, Vol. 346 Issue 8984, p1184. 6p. 4 Charts, 4 Graphs.

Subjects: Angina pectoris treatment

The agonising negative trend in monitoring of clinical trials.

Authors: DeMets, David L. Pocock, Stuart J. Julian, Desmond G.

Source: Lancet. 12/4/1999, Vol. 354 Issue 9194, p1983-1988. 6p. 2 Charts, 2 Graphs.

Subjects: Clinical trials, Clinical medicine research, Medical experimentation on humans, Medical research

Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting.

Authors: Henderson, Robert A. Pocock, Stuart J. Sharp, Stephen J. et al.

Source: Lancet. 10/31/1998, Vol. 352 Issue 9138, p1419-1425. 7p. 1 Diagram, 3 Charts, 5 Graphs.

Subjects: Transluminal angioplasty, Coronary artery bypass, Myocardial revascularization, Coronary heart disease surgery, Angina pectoris treatment

Geographic Terms: United Kingdom